Are cognitive interventions for Multiple Sclerosis effective and feasible?

Restorative Neurology and Neuroscience

Volumn 32, Issue 5, 2014, Pages 623-638

  Magalhães, Rosana ^a   Alves, Jorge ^a   Thomas, Roger E ^b   Chiaravalloti, Nancy ^c,d   Gonçalves, Óscar F ^a,e,f   Petrosyan, Agavni ^a,g   Sampaio, Adriana ^b  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF CALGARY   (Canada)

^c KESSLER FOUNDATION   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e NORTHEASTERN UNIVERSITY   (United States)

^f and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

feasibility; meta analysis; multiple sclerosis; Rehabilitation; systematic review

Indexed keywords

ARTICLE; COGNITION; COGNITIVE THERAPY; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; FEASIBILITY STUDY; FOLLOW UP; HUMAN; META ANALYSIS; MOOD; MULTIPLE SCLEROSIS; PATIENT ASSESSMENT; PROTOCOL COMPLIANCE; RISK; SYSTEMATIC REVIEW; BIBLIOGRAPHIC DATABASE; COGNITION DISORDERS; COMPLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS AND NUMERICAL DATA;

COGNITION DISORDERS; DATABASES, BIBLIOGRAPHIC; FEASIBILITY STUDIES; HUMANS; MULTIPLE SCLEROSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84907857850     PISSN: 09226028     EISSN: 18783627     Source Type: Journal    
DOI: 10.3233/RNN-140388     Document Type: Article

References (69)

1. Alves, J., Magalhaes, R., Thomas, R.E., Goncalves, O.F., Petrosyan, A., & Sampaio, A. (2013). Is there evidence for cognitive intervention in Alzheimer disease?. A systematic review of efficacy, feasibility, and cost-effectiveness. Alzheimer Dis Assoc Disord, 27(3), 195-203
2. Amato, M.P., Langdon, D., Montalban, X., Benedict, R.H., Deluca, J., Krupp, L.B., et al., (2013). Treatment of cognitive impairment in multiple sclerosis: Position paper. J Neurol, 260(6), 1452-1468
3. Amato, M.P., Ponziani, G., Siracusa, G., & Sorbi, S. (2001). Cognitive dysfunction in early-onset multiple sclerosis: A reappraisal after 10 years. Arch Neurol, 58(10), 1602-1606
4. Ball, K., Berch, D.B., Helmers, K.F., Jobe, J.B., Leveck, M.D., Marsiske, M., et al. (2002). Effects of cognitive training interventions with older adults: A randomized controlled trial. JAMA, 288(18), 2271-2281
5. Benedict, R.H., Amato, M.P., Boringa, J., Brochet, B., Foley, F., Fredrikson, S., et al. (2012). Brief International Cognitive Assessment for MS (BICAMS): International standards for validation. BMC Neurol, 12, 55
6. Benedict, R.H., Cookfair, D., Gavett, R., Gunther, M., Munschauer, F., Garg, N., & Weinstock-Guttman, B. (2006). Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc, 12(4), 549-558
7. Benedict, R.H., & Walton, M.K. (2012). Evaluating cognitive outcome measures for MS clinical trials: What is a clinically meaningful change?. Mult Scler, 18(12), 1673-1679
8. Brassington, J.C., & Marsh, N.V. (1998). Neuropsychological aspects of multiple sclerosis. Neuropsychol Rev, 8(2), 43-77
9. Brenk, A., Laun, K., & Haase, C.G. (2008). Short-term cognitive training improves mental efficiency and mood in patients with multiple sclerosis. Eur Neurol, 60(6), 304-309
10. Brissart, H., Leroy, M.,&Debouverie, M. (2010). Cognitive rehabilitation in multiple sclerosis: Preliminary results and presentation of a new program, PROCOG-SEP. Rev Neurol (Paris), 166(4), 406-411
11. Cerasa, A., Gioia, M.C., Valentino, P., Nistico, R., Chiriaco, C., Pirritano, D., et al. (2013). Computer-Assisted cognitive rehabilitation of attention deficits for multiple sclerosis: A randomized trial with FMRI correlates. Neurorehabil Neural Repair, 27(4), 284-295
12. Chiaravalloti, N.D., & DeLuca, J. (2008). Cognitive impairment in multiple sclerosis. Lancet Neurol, 7(12), 1139-1151
13. Chiaravalloti, N.D., DeLuca, J., Moore, N.B.,&Ricker, J.H. (2005). Treating learning impairments improves memory performance in multiple sclerosis: A randomized clinical trial. Mult Scler, 11(1), 58-68
14. Chiaravalloti, N.D., Stojanovic-Radic, J., & Deluca, J. (2013). The role of speed versus working memory in predicting learning newinformation in multiple sclerosis. J Clin Exp Neuropsychol, 35(2), 180-191
15. Chiaravalloti, N.D., Wylie, G., Leavitt, V., & Deluca, J. (2012). Increased cerebral activation after behavioral treatment for memory deficits in MS. J Neurol, 259(7), 1337-1346
16. das Nair, R., Ferguson, H., Stark, D.L., & Lincoln, N.B. (2012). Memory Rehabilitation for people with multiple sclerosis. Cochrane Database Syst Rev 3, CD008754
17. das Nair, R., & Lincoln, N.B. (2012). Evaluation of rehabilitation of memory in neurological disabilities (ReMiND): A randomized controlled trial. Clin Rehabil, 26(10), 894-903
18. DeLuca, J. (2006). What We Know about Cognitive Changes in Multiple Sclerosis. In: N. LaRocca & R. Kalb (Eds.), Multiple Sclerosis: Understanding the cognitive challenges (pp. 17-39). New York: Demos Medical Publishing.
19. DeLuca, J., Barbieri-Berger, S., & Johnson, S.K. (1994). The nature of memory impairments in multiple sclerosis: Acquisition versus retrieval. J Clin Exp Neuropsychol, 16(2), 183-189
20. DeLuca, J., Chelune, G.J., Tulsky, D.S., Lengenfelder, J., & Chiaravalloti, N.D. (2004). Is speed of processing or working memory the primary information processing deficit in multiple sclerosis?. J Clin Exp Neuropsychol, 26(4), 550-562
21. Erickson, K.I., Voss, M.W., Prakash, R.S., Basak, C., Szabo, A., Chaddock, L., et al. (2011). Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A, 108(7), 3017-3022
22. Fink, F., Rischkau, E., Butt, M., Klein, J., Eling, P., & Hildebrandt, H. (2010). Efficacy of an executive function intervention programme in MS: A placebo-controlled and pseudo-randomized trial. Mult Scler, 16(9), 1148-1151
23. Freeman, J.A., & Playford, E.D. (2012). Rehabilitation therapy in MS; a short-term, expensive, placebo. Mult Scler, 18(10), 1379-1381
24. Goverover, Y., Basso, M., Wood, H., Chiaravalloti, N., & DeLuca, J. (2011). Examining the benefits of combining two learning strategies on recall of functional information in persons with multiple sclerosis. Mult Scler, 17(12), 1488-1497
25. Goverover, Y., Genova, H.M., Hillary, F.G., & DeLuca, J. (2007). The relationship between neuropsychological measures and the Timed Instrumental Activities of Daily Living task in multiple sclerosis. Mult Scler, 13(5), 636-644
26. Grima, D.T., Torrance, G.W., Francis, G., Rice, G., Rosner, A.J., & Lafortune, L. (2000). Cost and health related quality of life consequences of multiple sclerosis. Mult Scler, 6(2), 91-98
27. He, D., Zhou, H., Guo, D., Hao, Z.,&Wu, B. (2011). Pharmacologic treatment for memory disorder in multiple sclerosis. Cochrane Database Syst Rev (10), CD008876
28. Higgins, J.P., Thompson, S.G., Deeks, J.J., & Altman, D.G. (2003). Measuring inconsistency in meta-Analyses. BMJ, 327(7414), 557-560
29. Hildebrandt, H., Lanz, M., Hahn, H.K., Hoffmann, E., Schwarze, B., Schwendemann, G., & Kraus, J.A. (2007). Cognitive training in MS: Effects and relation to brain atrophy. Restor Neurol Neurosci, 25(1), 33-43
30. Kobelt, G., Berg, J., Lindgren, P., Fredrikson, S., & Jonsson, B. (2006). Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry, 77(8), 918-926
31. Krupp, L.B., Christodoulou, C., Melville, P., Scherl,W.F.,MacAllister, W.S., & Elkins, L.E. (2004). Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology, 63(9), 1579-1585
32. Krupp, L.B., Christodoulou, C., Melville, P., Scherl,W.F., Pai, L.Y., Muenz, L.R., et al. (2011). Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis. Neurology, 76(17), 1500-1507
33. Landi, D., & Rossini, P.M. (2010). Cerebral restorative plasticity from normal ageing to brain diseases: A "never ending story". Restor Neurol Neurosci, 28(3), 349-366
34. Lincoln, N.B., Dent, A., Harding, J., Weyman, N., Nicholl, C., Blumhardt, L.D., & Playford, E.D. (2002). Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis. J Neurol Neurosurg Psychiatry, 72(1), 93-98
35. Lustig, C., Shah, P., Seidler, R., & Reuter-Lorenz, P.A. (2009). Aging, training, and the brain: A review and future directions. Neuropsychol Rev, 19(4), 504-522
36. Mattioli, F., Stampatori, C., Scarpazza, C., Parrinello, G., & Capra, R. (2012). Persistence of the effects of attention and executive functions intensive rehabilitation in relapsing remitting multiple sclerosis. Multiple Sclerosis and Related Disorders, 1(4), 168-173
37. Mattioli, F., Stampatori, C., Zanotti, D., Parrinello, G., & Capra, R. (2010). Efficacy and specificity of intensive cognitive rehabilitation of attention and executive functions in multiple sclerosis. J Neurol Sci, 288(1-2), 101-105
38. McCarthy, M., Beaumont, J.G., Thompson, R., & Peacock, S. (2005). Modality-specific aspects of sustained and divided attentional performance in multiple sclerosis. Arch Clin Neuropsychol, 20(6), 705-718
39. Mendozzi, L., Pugnetti, L., Motta, A., Barbieri, E., Gambini, A., & Cazzullo, C.L. (1998). Computer-Assisted memory retraining of patients with multiple sclerosis. Ital J Neurol Sci, 19, S431-S438
40. Moher, D., Liberati, A., Tetzlaff, J., & Altman, D.G. (2009). Preferred reporting items for systematic reviews and metaanalyses: The PRISMA statement. PLoS Med, 6(7), e1000097
41. Morrow, S.A., Drake, A., Zivadinov, R., Munschauer, F.,Weinstock- Guttman, B., & Benedict, R.H. (2010). Predicting loss of employment over three years in multiple sclerosis: Clinically meaningful cognitive decline. Clin Neuropsychol, 24(7), 1131-1145
42. Morrow, S.A., Kaushik, T., Zarevics, P., Erlanger, D., Bear, M.F., Munschauer, F.E., & Benedict, R.H. (2009). The effects of Lamphetamine sulfate on cognition in MS patients: Results of a randomized controlled trial. J Neurol, 256(7), 1095-1102
43. Moss-Morris, R., McCrone, P.,Yardley, L., vanKessel, K.,Wills, G., &Dennison, L. (2012).Apilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue. Behav Res Ther, 50(6), 415-421
44. Motl, R.W., Sandroff, B.M., & Benedict, R.H. (2011). Cognitive dysfunction and multiple sclerosis: Developing a rationale for considering the efficacy of exercise training. Mult Scler, 17(9), 1034-1040
45. NICE. (2003). Management of MS in primary and secondary care. Clinical guideline 8. London: National Institute for Clinical Excellence.
46. NMSS. (2008). Assessment and Management of Cognitive Impairment in Multiple Sclerosis. Treatment Recommendations for Physicians. Retrieved July 6, 2013, from http://www.nationalmssociety.org
47. O'Brien, A.R., Chiaravalloti, N., Goverover,Y.,&Deluca, J. (2008). Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: A review of the literature. Arch Phys Med Rehabil, 89(4), 761-769
48. Oswald,W.D., Gunzelmann, T., Rupprecht, R., & Hagen, B. (2006). Differential effects of single versus combined cognitive and physical training with older adults: The SimA study in a 5-year perspective. European Journal of Ageing, 3(4), 179-192
49. Owsley, C., Sloane, M., McGwin, G., Jr., & Ball, K. (2002). Timed instrumental activities of daily living tasks: Relationship to cognitive function and everyday performance assessments in older adults. Gerontology, 48(4), 254-265
50. Rao, S.M., Grafman, J., DiGiulio, D., Mittenberg, W., Bernardin, L., Leo, G.J., et al. (1993). Memory dysfunction in multiple sclerosis: Its relation to working memory, semantic encoding, and implicit learning. Neuropsychology, 7, 364-374
51. Rao, S.M., Leo, G.J., Bernardin, L., & Unverzagt, F. (1991). Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology, 41(5), 685-691
52. RevMan. (2012). Review Manager (RevMan) [Computer program] (Version Version 5.2.3). Copenhagen: The Nordic Cochrane Centre: The Cochrane Collaboration.
53. Rosti-Otajarvi, E.M., & Hamalainen, P.I. (2011). Neuropsychological rehabilitation for multiple sclerosis. Cochrane Database Syst Rev (11), CD009131
54. Rosti-Otajarvi, E.M., Mantynen, A., Koivisto, K., Huhtala, H., & Hamalainen, P. (2013a). Neuropsychological rehabilitation has beneficial effects on perceived cognitive deficits in multiple sclerosis during nine-month follow-up. J Neurol Sci, 334(1-2), 154-160
55. Rosti-Otajarvi, E.M., Mantynen, A., Koivisto, K., Huhtala, H., & Hamalainen, P. (2013b). Patient-related factors may affect the outcome of neuropsychological rehabilitation in multiple sclerosis. J Neurol Sci, 334(1-2), 106-111
56. Sandroff, B.M., Klaren, R.E., Pilutti, L.A., Dlugonski, D., Benedict, R.H.,&Motl, R.W (2014). Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis. J Neurol, 261(2), 363-372
57. Scarpazza, C., Braghittoni, D., Casale, B., Malagu, S., Mattioli, F., di Pellegrino, G., & Ladavas, E. (2013). Education protects against cognitive changes associated with multiple sclerosis. Restor Neurol Neurosci, 31(5), 619-631
58. Shatil, E., Metzer, A., Horvitz, O., & Miller, A. (2010). Homebased personalized cognitive training in MS patients: A study of adherence and cognitive performance. NeuroRehabilitation, 26(2), 143-153
59. Smith, A (1982). Symbol Digit Modality Test,Western Psychological Services, Los Angeles, CA.
60. Solari, A., Motta, A., Mendozzi, L., Pucci, E., Forni, M., Mancardi, G., & Pozzilli, C. (2004). Computer-Aided retraining of memory and attention in people with multiple sclerosis: A randomized, double-blind controlled trial. J Neurol Sci, 222(1-2), 99-104
61. Stern, Y. (2002). What is cognitive reserve?. Theory and research application of the reserve concept. J Int Neuropsychol Soc, 8(3), 448-460
62. Strober, L., Chiaravalloti, N., Moore, N., & Deluca, J. (2013). Unemployment in multiple sclerosis (MS): Utility of the MS Functional Composite and cognitive testing. Mult Scler.
63. Stuifbergen, A.K., Becker, H., Perez, F., Morison, J., Kullberg, V.,& Todd, A. (2012). A randomized controlled trial of a cognitive rehabilitation intervention for persons with multiple sclerosis. Clin Rehabil, 26(10), 882-893
64. Sumowski, J.F., Chiaravalloti, N., Erlanger, D., Kaushik, T., Benedict, R.H., & DeLuca, J. (2011). L-Amphetamine improves memory in MS patients with objective memory impairment. Mult Scler, 17(9), 1141-1145
65. Sumowski, J.F., Rocca, M.A., Leavitt,V.M., Riccitelli, G., Comi, G., Deluca, J., & Filippi, M. (2013). Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it. Neurology, 80(24), 2186-2193
66. Sumowski, J.F., Wylie, G.R., Deluca, J., & Chiaravalloti, N. (2010). Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: Functional magnetic resonance imaging evidence for cognitive reserve. Brain, 133(Pt 2), 362-374
67. Tesar, N., Bandion, K., & Baumhackl, U (2005). Efficacy of a neuropsychological training programme for patients with multiple sclerosis - A randomised controlled trial.Wien KlinWochenschr, 117(21-22), 747-754
68. Thomas, P.W., Thomas, S., Hillier, C., Galvin, K., & Baker, R. (2006). Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev (1), CD004431
69. Vogt, A., Kappos, L., Calabrese, P., Stocklin, M., Gschwind, L., Opwis, K., & Penner, I.K. (2009).Working memory training in patients with multiple sclerosis - comparison of two different training schedules. Restor Neurol Neurosci, 27(3), 225-235